Addict Behav. 2006 Jul;31(7):1144-52. Epub 2005 Aug 30.

The prevalence of weight concerns in a smoking abstinence clinical trial.

Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA, Dakhil SR, Croghan GA, Wos EJ, Rowland KM, Bernath A, Morton RF, Thomas SP, Tschetter LK, Garneau S, Stella PJ, Ebbert LP, Wender DB, Loprinzi CL.

Source

Mayo Clinic - Mayo Building-W11, 200 First Street, SW, Rochester, MN 55905, USA. Clark.matthew@mayo.edu

Abstract

Recent research has demonstrated there is a high prevalence of weight concerns in smokers and that smokers with weight concerns may respond poorly to treatment for tobacco dependence. Most studies have focused only on females or have consisted of small samples. In this study of a 12-week randomized trial of nicotine inhaler, bupropion or both for smoking cessation, 50% of the 1012 female smokers and 26% of the 680 male smokers, at study entry, were weight concerned. In examining the impact of weight concerns on the 12-week point-prevalence smoking abstinence, 26% of non-weight-concerned smokers quit smoking compared to 22% of weight-concerned smokers (p=0.06). This study, which includes a large sample of both genders, provides further evidence that approximately half of females who are seeking smoking cessation treatment are weight concerned and that one quarter of male smokers are weight concerned. Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy.

PMID:: 16137833; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Outcomes from an outpatient smoking-cessation clinic. [Pharmacotherapy. 2005]
Outcomes from an outpatient smoking-cessation clinic.
Roth MT, Andrus MR, Westman EC. Pharmacotherapy. 2005 Feb; 25(2):279-88.
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. [J Clin Psychopharmacol. 2007]
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, et al. J Clin Psychopharmacol. 2007 Aug; 27(4):380-6.
Body image treatment for weight concerned smokers: a pilot study. [Addict Behav. 2005]
Body image treatment for weight concerned smokers: a pilot study.
Clark MM, Hays JT, Vickers KS, Patten CA, Croghan IT, Berg E, Wadewitz S, Schwartz S, Decker PA, Offord KP, et al. Addict Behav. 2005 Jul; 30(6):1236-40. Epub 2004 Nov 6.
Review A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. [Clin Ther. 2008]
Review A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Robles GI, Singh-Franco D, Ghin HL. Clin Ther. 2008 May; 30(5):800-12.
Review Smoking cessation interventions in clinical practice. [Eur J Vasc Endovasc Surg. 2007]
Review Smoking cessation interventions in clinical practice.
Cornuz J. Eur J Vasc Endovasc Surg. 2007 Oct; 34(4):397-404. Epub 2007 Aug 3.

See reviews... See all...

Cited by 9 PubMed Central articles

Weight Gain After Quitting: Attitudes, Beliefs and Counselling Strategies of Cessation Counsellors. [J Smok Cessat. 2008]
Weight Gain After Quitting: Attitudes, Beliefs and Counselling Strategies of Cessation Counsellors.
Bush T, Levine MD, Zbikowski S, Deprey M, Rabius V, McAfee T, Wiatrek DE. J Smok Cessat. 2008 Dec; 3(2):124-132.
Prevalence of Weight Concerns and Obesity Among Smokers Calling a Quitline. [J Smok Cessat. 2008]
Prevalence of Weight Concerns and Obesity Among Smokers Calling a Quitline.
Bush T, Levine MD, Deprey M, Cerutti B, Zbikowski SM, McAfee T, Mahoney L, Beebe L. J Smok Cessat. 2008 Dec 1; 4(5):74-78.
Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study. [BMC Complement Altern Med. 2010]
Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study.
Bock BC, Morrow KM, Becker BM, Williams DM, Tremont G, Gaskins RB, Jennings E, Fava J, Marcus BH. BMC Complement Altern Med. 2010 Apr 29; 10:14. Epub 2010 Apr 29.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The prevalence of weight concerns in a smoking abstinence clinical trial.
The prevalence of weight concerns in a smoking abstinence clinical trial.
Addict Behav. 2006 Jul ;31(7):1144-52. Epub 2005 Aug 30 .

PubMed
Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) redu...
Intermittent catheterisation with hydrophilic-coated catheters (SpeediCath) reduces the risk of clinical urinary tract infection in spinal cord injured patients: a prospective randomised parallel comparative trial.
Eur Urol. 2005 Dec ;48(6):991-5. Epub 2005 Aug 15 .

PubMed
The effect of multicolor playground markings on children's physical activity lev...
The effect of multicolor playground markings on children's physical activity level during recess.
Prev Med. 2005 Nov-Dec ;41(5-6):828-33. Epub 2005 Aug 31 .

PubMed
Sensorineural deafness inherited as a tissue specific mitochondrial disorder.
Sensorineural deafness inherited as a tissue specific mitochondrial disorder.
J Med Genet. 1992 Feb ;29(2):86-90.

PubMed
Effect of chitooligosaccharides on calcium bioavailability and bone strength in ...
Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats.
Life Sci. 2006 Jan 25 ;78(9):970-6. Epub 2005 Aug 30 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: